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BRIEF DEFINITIVE REPORT
        Airway hypersensitive reaction (AHR) (  1  ) is 
known to be associated with Th2 cytokines  —
  including IL-4, IL-5, and IL-13  —  regulating ef-
fector functions (  2  ). Indeed, overexpression of 
these Th2 cytokines results in the development 
of AHR (  3  ). However, eff  orts to ameliorate ex-
perimental asthma with antibodies against Th2 
cytokines have generally proven unsuccessful. 
Among these, only IL-13 seems to be a key cyto-
kine responsible for goblet cell hyperplasia, 
airway remodeling, and AHR (  4  ), because in-
hibition of IL-13 activity, but not that of other 
Th2 cytokines, by a blocking antibody suppresses 
both AHR and airway infl  ammation. 
  IL-25 (also known as IL-17E), a member of 
the structurally related IL-17 cytokine family 
(  5  –  7  ), has recently been reported to be produced 
by activated Th2 cells (  5  ) and mast cells (  8  ), re-
sulting in enhancement of AHR (  9, 10  ). Admin-
istration of a blocking antibody against IL-25 
(  11  ) or IL-25  –  defi  cient mice (  12  ) eliminates 
Th2 responses. Conversely, systemic expression 
of either human (  7  ) or mouse (  11  ) IL-25, or 
administration of recombinant IL-25 (  5  ), induces 
Th2-type immune responses, including increased 
serum IgE levels, blood eosinophilia, and patho-
logical changes in the lung and other tissues. 
These fi  ndings clearly demonstrate a pivotal role 
of IL-25 as a mediator of Th2 responses, sug-
gesting that IL-25 lies upstream of the classical 
Th2 cytokine responses (  5, 11  ). 
  NKT cells characterized by the expression 
of an invariant antigen receptor encoded by 
  V    14J    18   in mice or   V    24J    18   in humans are 
also involved in the development of asthma, 
because NKT cell  –  defi  cient J    18      /      mice fail to 
develop antigen-induced AHR (  13  ). Th2 cells 
are not always essential for NKT cell  –  mediated 
AHR development, because activation of NKT 
cells induces AHR in the absence of CD4  +   T 
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  Airway hypersensitive reaction (AHR) is an animal model for asthma, which is caused or 
enhanced by environmental factors such as allergen exposure. However, the precise 
mechanisms that drive AHR remain unclear. We identifi  ed a novel subset of natural killer 
T (NKT) cells that expresses the interleukin 17 receptor B (IL-17RB) for IL-25 (also 
known as IL-17E) and is essential for the induction of AHR. IL-17RB is preferentially 
expressed on a fraction of CD4  +   NKT cells but not on other splenic leukocyte populations 
tested. IL-17RB  +   CD4  +   NKT cells produce predominantly IL-13 and Th2 chemokines upon 
stimulation with IL-25 in vitro. IL-17RB  +   NKT cells were detected in the lung, and deple-
tion of IL-17RB  +   NKT cells by IL-17RB  –  specifi  c monoclonal antibodies or NKT cell  –
  defi  cient J    18      /      mice failed to develop IL-25  –  dependent AHR. Cell transfer of IL-17RB  +   
but not IL-17RB        NKT cells into J    18      /      mice also successfully reconstituted AHR induc-
tion. These results strongly suggest that IL-17RB  +   CD4  +   NKT cells play a crucial role in 
the pathogenesis of asthma. 
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(Fig. S1, available at http://www.jem.org/cgi/content/full/
jem.20080698/DC1) by immunization with a recombinant 
IL-17RB  –  Ig fusion protein (Fig. S2). We fi  rst investigated 
IL-17RB  +   cells in the spleen by mouse IL-17RB mAb to 
confi  rm the previous fi  ndings that IL-17RB expression is 
detected on a fraction of non  –  B/non  –  T (NBNT), c-kit  +  , 
Fc    RI        cells in the mesenteric lymph node (Fig. S3), which 
has identifi  ed as IL-4  –  , IL-5  –  , IL-13  –  producing cells in response 
to IL-25 (  12  ). NKT cells were distinct from the NBNT 
c-kit  +   cells based on the expression of c-kit       , Fc    RI       , V    14-
J    18  +   transcripts detected by RT-PCR (Fig. S4). Moreover, 
IL-17RB was preferentially expressed on a fraction of     -ga-
lactosylceramide (    -GalCer)/CD1d dimer  +   NKT cells but 
not on other cell types, including NBNT c-kit  +   cells, CD4  +   
T cells, CD8  +   T cells,           +   T cells, CD19  +   B cells, CD11c  +   
DCs, DX5  +   NK cells, or noninvariant NKT cells in the 
spleen (  Fig. 1 A  ).   
  The preferential expression of IL-17RB in a fraction of 
NKT cells raises a question about the phenotypic and functional 
cells in   MHC class II    –  defi  cient mice (  14  ). These fi  ndings sug-
gest that NKT cells are directly involved in the development 
of AHR independent of Th2 responses in some conditions. 
In this report, we investigated the role of IL-25 in NKT cell  –
  dependent AHR induction in mouse models and found that 
IL-17RB, a receptor for IL-25, was selectively expressed on 
a fraction of mouse NKT cells, which preferentially produced 
IL-13 and induced the development of AHR upon stimula-
tion with IL-25. 
    RESULTS AND DISCUSSION   
  We fi  rst investigated the role of IL-25 in the development of 
AHR in relation to NKT cells because of previous fi  ndings 
that IL-25 induces Th2-biased responses (  5  –  7  ). The receptor 
for IL-25, termed IL-17RB or EVI27/IL-17BR, was originally 
found to bind IL-17B (  15  ). Interestingly, however, the re-
ceptor binds IL-25 with higher affi   nity than IL-17B. There-
fore, this receptor is now termed IL-17RB/IL-25R (  15  ). To 
identify mouse IL-17RB  +   cells, we generated specifi  c mAbs 
    Figure 1.         Phenotypic and gene expression profi  les of splenic IL-17RB  +   NKT cells.   (A)  Identifi  cation of IL-17RB  +   cells from BALB/c mice. The indi-
cated populations were gated and analyzed by FACS using F(ab   ) 2   fragments of the anti  –  IL-17RB mAb B5F6. Shaded profi  les in the histograms indicate 
the background staining with rat F(ab   ) 2   IgG2a. (B) FACS profi  le of CD1d dimer  +   NKT cells stained with anti-CD4 and anti  –  IL-17RB. (C) Surface pheno-
type of DN, IL-17RB        CD4 +  , and IL-17RB  +   CD4 +   NKT cells indicated in B. Shaded profi  les in the histograms indicate the background staining with iso-
type-matched control antibody. Percentages are shown. (D  –  H) Quantitative analyses of genes for chemokine receptors (D), Th1-related molecules 
(E), Th2-related molecules (F), cytotoxic molecules (G), and Th17-related molecules (H) in isolated DN (black bars), IL-17RB        CD4 +   (gray bars), and IL-
17RB  +   CD4 +   (white bars) NKT cells. Expression of each mRNA was determined by quantitative real-time PCR using the primer sets shown in Table S1 
(available at http://www.jem.org/cgi/content/full/jem.20080698/DC1) and is depicted as the number of transcripts per one copy of the housekeeping 
gene HPRT. One representative out of three experiments is shown (means   ±   SEM).     JEM VOL. 205, November 24, 2008  2729
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production (  21  ) and for IL-21 production (  22  ), in NKT cell 
activation.   Under these conditions, IL-25  –  activated IL-17RB  +   
NKT cells mainly produced IL-13, along with modest produc-
tion of IL-4, but barely produced IFN-     (  Fig. 2 B  ). Moreover, 
IL-17RB  +   NKT cells produced Th2 chemokines such as 
thymus and activation-regulated chemokine/CCL17, mac-
rophage-derived chemokine/CCL22, and C10/CCL6 as well 
as eosinophil chemotactic factor  –  L (ECF-L) upon stimula-
tion with IL-25 (  Fig. 2 C  ). These results indicate that IL-25 
triggers IL-17RB  +   NKT cells to preferentially produce the 
IL-13, Th2 chemokines, and ECF-L important for recruit-
ment of eosinophils. 
  Recently, other IL-17 family members, IL-17A or IL-17F, 
have been shown to be involved in chronic infl  ammatory and 
allergic lung diseases (  23, 24  ). The expression levels of   IL-17A   
mRNA in IL-17RB  +   NKT cells were slightly elevated after 
treatment with IL-25 (  Fig. 2 C  ). However, levels of   IL-17A   
and   ROR    t   mRNA in IL-17RB  +   NKT cells were lower than 
those in DN NKT cells (  Fig. 1 H  ). Because high expression of 
  ROR    t   is one of the markers for Th17 cells, low expression of 
  ROR    t   in IL-17RB  +   NKT cells (  Fig. 1 H  ) indicates that IL-
17RB  +   NKT cells are distinct from IL-17  –  producing NKT 
cells. In addition, even though NK1.1-negative NKT cells 
represent IL-17  –  producing cells in C57BL/6 mice (  25, 26  ), it 
characteristics of these cells. Based on our current understanding, 
NKT cells are divided into two populations based on CD4/
CD8 expression: a CD4  +   and a CD4       CD8        double-negative 
(DN) population (  16  ). Using an IL-17RB mAb, we found that 
one third of the CD4  +   but none of the DN NKT cells ex-
pressed IL-17RB, indicating the existence of three subpopula-
tions: DN, IL-17RB        CD4  +  , and IL-17RB  +   CD4  +   NKT 
cells (  Fig. 1 B  ). Moreover, the majority of IL-17RB  +   NKT 
cells were dimly positive for CD69 and CD122 compared 
with brightly positive DN NKT and IL-17RB        CD4  +   NKT 
cells (  Fig. 1 C  ). The expression level of CD62L by IL-17RB  +   
NKT cells was low, comparable to that on IL-17RB        CD4  +   
NKT cells and similar to that of conventional memory T cells, 
whereas it was quite high on DN NKT cells. In addition, IL-
17RB  +   NKT cells (3%), like IL-17RB        CD4  +   NKT cells 
(11%), barely expressed an NK receptor, NKG2D, which was 
highly expressed on the majority (  >  60%) of DN NKT cells, 
suggesting their cytotoxic nature (  17  ). 
  To investigate cytokine and chemokine gene expression 
profi  les on IL-17RB  +   NKT cells, we performed quantitative 
real-time PCR using primer sets as shown in Table S1 (available 
at http://www.jem.org/cgi/content/full/jem.20080698/DC1). 
The expression of the Th2 chemokine receptor   CCR4   was 
several times higher on IL-17RB  +   NKT cells than on the 
other subsets, whereas no signifi  cant diff  erences were found 
in   CXCR6   expression (  Fig. 1 D  ), which is important for NKT 
cell migration (  18  ). The results are consistent with the previ-
ous fi  ndings that NKT cells require CCR4 to localize to the 
airways and to induce AHR (  19  ). 
  Concerning cytokine production of IL-17RB  +   NKT cells, 
it is reported that NKT cells produce both Th1 and Th2 cyto-
kines at the same time upon stimulation with their ligand, 
    -GalCer (  20  ). Surprisingly, IL-17RB  +   NKT cells expressed 
lower levels of Th1-related transcripts, such as   IFN-      ,   T-bet  ,   
Stat4  ,   IL-18R      , and   IL-12R    2   (  Fig. 1 E  ), whereas higher 
levels of the Th2-related transcript   IL-4   were detected 
(  Fig. 1 F  ). In contrast, transcripts for cytotoxic eff  ector mol-
ecules, such as   Granzyme  ,   Perforin  , and   killer receptors   (  KIRa1  , 
  KIRc1  ,   KIRd1  , and   KIRg1)  , were expressed mainly in DN 
NKT cells (  Fig. 1 G  ), supporting the previous fi  ndings that 
DN NKT but not CD4  +   NKT cells predominantly mediate 
antitumor immunity (  19  ) and also that NKG2D was predom-
inantly expressed on DN NKT cells, as shown in   Fig. 1 C  . The 
expression levels of   IL-17A   and   ROR    t   transcripts in IL-
17RB  +   NKT cells, which are high in Th17 cells, were lower 
than those in DN NKT cells (  Fig. 1 H  ). These results on sur-
face phenotypes and mRNA expression profi  les clearly indi-
cate that IL-17RB  +   NKT cells are Th2-type NKT cells and 
are distinct from other NKT cells, such as DN NKT cells or 
IL-17  –  producing NKT cells. 
  Next, we analyzed the function of IL-17RB  +   NKT cells 
in response to IL-25 in vitro. IL-17RB  +   NKT but not CD4  +   
IL-17RB        nor DN NKT cells responded to IL-25 in a dose-
dependent manner only in the presence of APCs (  Fig. 2 A  ), 
which is similar to previous fi  ndings on the requirement of 
two signals, such as IL-12 and CD1d on APCs for IFN-     
    Figure 2.         Properties of splenic IL-17RB  +   CD4  +   NKT cells.   (A and B) 
Proliferation (A) and cytokine production (B) of DN, IL-17RB        CD4 + ,  and 
IL-17RB  +   CD4 +   NKT cells. Indicated NKT cell subpopulations (10  6   cells/ml) 
were co-cultured for 3 d with or without splenic CD11c  +   DCs  (10 5   cells/ml) 
in the absence or presence of IL-25 (0, 1, and 10 ng/ml), and proliferation 
was assayed by [  3  H]thymidine incorporation (A) or cytokine production by 
cytokine bead array (B). The data are shown as the means   ±   SD of three 
cultures. The data are representative of four independent experiments. 
(C) Quantitative analysis of genes in IL-17RB  +   CD4 +   NKT cells. IL-17RB  +  
CD4  +   NKT cells (10  6   cells/ml) were co-cultured with splenic CD11c  +   DCs 
(10  5   cells/ml) in the presence of 10 ng/ml IL-25 for 48 h. IL-17RB  +   CD4 +  
NKT cells were sorted and analyzed for their gene expression by quantita-
tive real-time PCR, as described in Materials and methods. The data are 
representative of three independent experiments (means   ±   SEM).     2730 MOUSE NKT CELLS BEARING IL-17RB CONTRIBUTE TO AIRWAY HYPERREACTIVITY   | Terashima et al. 
.org/cgi/content/full/jem.20080698/DC1). We also found 
that IL-17RB  +   NKT cells were detected more in the lung and 
spleen than the thymus but were almost undetectable in the 
liver. Although the number of NKT cells in the lung was one 
tenth of that in the spleen or the thymus, IL-17RB  +   NKT cells 
make up a higher proportion in the total NKT cells in the 
lung (  Fig. 3 A  ).   Similar to the splenic NKT cells shown in 
  Fig. 1 A  , the selective expression of IL-17RB on NKT cells was 
also detected in the lung, whereas conventional CD4  +   T,           +   
T, c-kit  +   NBNT, and noninvariant NKT cells in the lung 
were negative or barely detectable (  Fig. 3 B  ). 
  To determine whether IL-17RB  +   NKT cells are re-
quired for IL-25 in the development of AHR, WT mice were 
has also been reported that IL-17  –  producing NKT cells are 
not restricted to a particular NKT cell subset (  27  ). Another 
report has also revealed that ozone- but not allergen-induced 
AHR requires IL-17A produced from both NKT and T cells 
(  28  ). These results suggest that IL-17RB  +   NKT cells described 
in this report are not equivalent to IL-17A  –  producing NKT 
cells reported by others. 
  We further examined whether the frequency of IL-17RB  +   
NKT cells diff  ers among mouse strains because allergic re-
sponses are strain dependent. Intriguingly, IL-17RB  +   NKT 
cells were fairly abundant in Th2-prone BALB/c and DBA2/
cr mice but were barely detectable in Th1-prone C57BL/6 
and C3H/HeN mice (Fig. S5, available at http://www.jem
    Figure 3.         Involvement of IL-17RB  +   NKT cells in the development of IL-25  –  induced AHR.   (A and B) Tissue distribution of IL-17RB  +   NKT  cells 
(A) and IL-17RB expression among lung mononuclear cell populations (B) in BALB/c mice.    -GalCer/CD1d  dimer +   NKT cells in the indicated organs (A) and 
mononuclear cell populations in the lung (B) from BALB/c mice were gated and analyzed by FACS using B5F6 F(ab   ) 2   IL-17RB mAb. Shaded profi  les in the 
histograms indicate the background staining with rat F(ab   ) 2   IgG2a  ( n   = 3). Percentages are shown. (C) Development of AHR. The changes in R  L   were  mea-
sured. The detailed method for development of OVA/IL-25  –  induced AHR is described in Materials and methods. Results are expressed as the mean   ±   SEM. 
The group of IL-25  –  treated WT mice was compared with three other groups. *, P   <   0.05; and **, P   <   0.01 calculated by ANOVA. The results represent one 
out of three experiments with fi  ve mice in each group. (D and G) Total and differential cell counts (D) and cytokines (G) in BAL fl  uid. BAL fl  uid was col-
lected 24 h after challenge with intranasal OVA of the mice depicted in C. IL-25  –  induced pulmonary infl  ammation (D) and IL-13 and IL-5 production 
(G) were reduced in J   18    /     mice. The data on cytokines in G are expressed as the amounts detected in the 10-fold PBS-diluted BAL samples. Results are 
expressed as means   ±   SEM. *, P   <   0.05; **, P   <   0.01. The group of IL-25  –  treated WT mice was compared with three other groups. These results represent 
one out of four experiments with fi  ve mice in each group. (E and F) Histological analysis of lung tissues with hematoxylin and eosin (E) and periodic acid 
Schiff (F) staining. IL-25  –  treated WT (c) or J   18    /     (d) mice were compared with WT (a) or J   18    /     (b) mice from control (  n   =  4).  Bars,100   μ m.   JEM VOL. 205, November 24, 2008  2731
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by OVA plus IL-25, indicating that IL-17RB  +   NKT cells in 
the lung are functionally equivalent to those in the spleen. In 
addition, when equal numbers of cells were transferred, the 
severity of AHR induced by enriched IL-17RB  +   NKT cells 
was almost three times higher than the total spleen NKT 
cells (  Fig. 4 D  ), consistent with the ratio of IL-17RB  +   NKT 
cells (  Fig. 1 B  ). This indicates that the severity of AHR de-
pends on the cell numbers of IL-17RB  +   NKT cells trans-
ferred ( Fig. 4 D ) and, thus, that IL-17RB  +   NKT cells contribute 
to the development of IL-25  –  dependent AHR. 
immunized with a suboptimal dose of OVA/alum twice and 
were subsequently treated with PBS before a single intranasal 
OVA challenge (see Materials and methods). Under these 
conditions, the mice failed to develop AHR. When the mice 
were subsequently treated with IL-25 instead of PBS, they 
developed AHR (  Fig. 3 C  ). In contrast, even after treat-
ment with IL-25, NKT cell  –  defi  cient J    18      /      mice failed to 
develop signifi  cant AHR, comparable to that seen in the PBS-
treated control mice (  Fig. 3 C  ). Unlike WT mice, J    18      /      
mice treated with IL-25 signifi  cantly reduced numbers of air-
way macrophages, eosinophils, neutrophils, and lymphocytes 
in the lung (  Fig. 3 D  ). 
  Hematoxylin and eosin staining of the lung tissue of IL-
25  –  treated WT mice revealed that the levels of infi  ltration of 
infl  ammatory mononuclear cells into the peribronchiolar re-
gion were higher in WT mice with severe tissue destruction 
compared with those in J    18      /      mice. No infl  ammatory cell 
infi  ltration was detected in untreated WT or J    18      /      mice 
(  Fig. 3 E  ). By periodic acid Schiff   staining, mucus-producing 
cells were abundant only in IL-25  –  treated WT but not J    18      /      
mice (  Fig. 3 F  ). To further investigate the eff  ects on allergic 
responses mediated by IL-17RB  +   NKT cells, we examined 
cytokine production in the bronchoalveolar lavage (BAL) fl  uid 
of IL-25  –  treated WT or J    18           /            mice and controls. The pro-
duction of IL-5 and IL-13, which plays a crucial role in the 
recruitment of eosinophils and Th2 cells, respectively, were 
detected only in IL-25  –  treated WT mice (  Fig. 3 G  ). Even 
though IL-17RB  +   NKT cells did not produce IL-5 upon 
IL-25 stimulation (  Fig. 2 B  ), they produced ECF-L (  Fig. 2 C  ), 
which is important for the recruitment of eosinophils produc-
ing IL-5. These results strongly suggest that IL-25 acts directly 
on NKT cells and induces AHR. 
  We then investigated whether IL-17RB  +   NKT cells are 
involved in the development of IL-25  –  dependent AHR, and 
we depleted IL-17RB  +   cells with 3H8 IL-17RB mAb. Among 
the NKT cell populations, the majority of IL-17RB  +   NKT 
cells were     -GalCer/CD1d dimer  hi   TCR      hi  , indicating that 
the expression level of TCR     and TCR     on IL-17RB  +   NKT 
cells was higher than that on other IL-17RB        NKT cells (  Fig. 
4 A  ).   IL-17RB  +   NKT depletion persisted for at least 5 d after 
3H8 IL-17RB mAb injection (  Fig. 4 B  ), whereas no eff  ects 
were detected on other cell types, such as CD4  +   T,           +   T, 
and NBNT c-kit  +   cells (Fig. S6, available at http://www.jem
.org/cgi/content/full/jem.20080698/DC1). As expected, 
treatment of 3H8 IL-17RB mAb signifi  cantly induced sup-
pression of AHR (  Fig. 4 C  ), which was tightly correlated with 
the reduction of the number of IL-17RB  +   NKT cells (  Fig. 4 B  ). 
Administration of an isotype-matched control mAb did not 
suppress AHR (  Fig. 4 C  ), and the number of IL-17RB  +   NKT 
cells remained unchanged (  Fig. 4 B  ). 
  To confi  rm the fi  ndings that IL-17RB  +   NKT cells are 
essential for the development of IL-25  –  dependent AHR, we 
transferred enriched splenic IL-17RB  +   NKT cells into J    18      /      
mice and tested their ability to develop IL-25  –  dependent AHR 
(  Fig. 4 D  ). The cell transfer of IL-17RB  +   NKT cells, but not 
IL-17RB        NKT cells nor PBS alone, restored AHR induced 
    Figure 4.         Requirement of IL-17RB  +   NKT cells in the development 
of IL-25  –  induced AHR.   (A) FACS profi  les of NKT cells in the expression 
of IL-17RB.    -GalCer/CD1d  dimer hi   TCR   hi   NKT cells and    -GalCer/CD1d 
dimer  int   TCR   int   NKT cells in the spleen from BALB/c mice were gated, and 
IL-17RB expression was analyzed using F(ab   ) 2   IL-17RB mAb B5F6. IL-
17RB was preferentially expressed in    -GalCer/CD1d  dimer hi   TCR   hi   NKT 
cells (  n   = 3). (B) FACS profi  les of NKT cells in mice treated with IL-17RB 
mAb.    -GalCer/CD1d  dimer +   TCR   +   NKT cells in the spleen from BALB/c 
mice at the indicated days after injection of 3H8 IL-17RB mAb or control 
rat IgG2a (1 mg/mouse) were gated and analyzed by FACS. Depletion of 
IL-17RB  +   NKT cells persisted for at least 5 d after 3H8 injection because 
of the absence of    -GalCer/CD1d  dimer hi   TCR   hi   NKT cells in A (  n   =  2). 
Percentages are shown. (C) Development of AHR in mice treated with IL-
17RB mAb. The detailed method for development of OVA/IL-25  –  induced 
AHR is described in Materials and methods. In brief, OVA/alum-sensitized 
mice were injected with 3H8 IL-17RB mAb or rat IgG2a (1 mg/mouse) 
24 h before 2   μ  g IL-25 or PBS treatment and were challenged with OVA 
after 24 h, and R  L   was determined after 48 h. The group of rat IgG2a  –
  treated WT mice was compared with three other groups. Results are 
expressed as means   ±   SEM. The results represent one out of three experi-
ments with fi  ve mice in each group. *, P   <   0.05; and **, P   <   0.01 calcu-
lated by ANOVA. (D) AHR development after cell transfer of spleen 
IL-17RB  +   NKT cells into J   18    /     mice. The detailed method for develop-
ment of OVA/IL-25  –  induced AHR is described in Materials and methods. 
Indicated cell numbers of sorted IL-17RB  + ,  IL-17RB       NKT, or total NKT 
cells from spleen or PBS control were intravenously transferred into OVA/
alum-sensitized J   18    /     mice 24 h before treatment with 3   μ  g IL-25 and 
were challenged with OVA after 24 h, and R  L   was measured after 48 h. 
Each group of IL-17RB  +   NKT cell  –  transferred mice was compared with 
three other groups. *, P   <   0.05; and **, P   <   0.01 calculated by the 
Kruskal-Wallis test. The results represent one out of four experiments 
with fi  ve mice in each group. Results are expressed as means   ±   SEM.     2732 MOUSE NKT CELLS BEARING IL-17RB CONTRIBUTE TO AIRWAY HYPERREACTIVITY   | Terashima et al. 
  Flow cytometry.     Antibodies used for fl  ow cytometric analysis were as fol-
lows: FITC anti  –  mouse TCR     (H57-597; BD), Pacifi  c blue anti  –  mouse CD4 
(RM4-5; BD), PerCP-Cy5.5 anti  –  mouse CD8     (53-6.7; BD), PE anti  –  mouse 
CD44 (IM7; BD), PE anti  –  mouse CD122 (TM-    1; BD), PE anti  –  mouse 
CD62L (MEL-14; BD), and PE anti  –  mouse NKG2D (C7; eBioscience). 
  Proliferation assay.     Proliferation assays were done in 96-well U-bottomed 
plates. The spleen cell cultures were incubated for 3 d and pulsed with 0.037 
MBq/well of [  3  H]thymidine (GE Healthcare) for the last 16 h. Radioactivity 
was measured using a MicroBeta (PerkinElmer). 
  Quantitative real-time PCR.     The PCR was performed with the Plati-
num SYBR Green qPCR SuperMix-UGD kit with ROX (Invitrogen) ac-
cording to the protocol provided. A sequence detection system (ABI PRISM 
7900HT; Applied Biosystems) was used for quantitative real-time PCR 
according to the manufacturer  ’  s instructions. To ensure the specifi  city of the 
amplifi  cation products, a melting curve analysis was performed. Results were 
normalized using the internal control gene HPRT. Sequences of PCR prim-
ers (Table S1) were designed with Primer Express software (Applied Biosys-
tems) for optimal product length, germinal center content, and Tm value. 
  Statistical analysis.     The statistical signifi  cance of diff  erences was determined 
by analysis of variance (ANOVA) or the Kruskal-Wallis test. The values were 
expressed as means   ±   SEM from independent experiments. Any diff  erence with 
a p-value of   <  0.05 was considered signifi  cant (*, P   <   0.05; **, P   <   0.01). 
  Online supplemental material.     Fig. S1 shows generation of mouse IL-
17RB  –  specifi  c mAbs. Fig. S2 shows expression and purifi  cation of mouse 
IL-17RB  –  Ig fusion protein. Fig. S3 shows FACS profi  les of cells stained 
with mouse IL-17RB  –  specifi  c mAbs. Fig. S4 shows RT-PCR analysis on 
c-kit  +   NBNT cells and NKT cell subsets. Fig. S5 provides IL-17RB  +   NKT 
cells in diff  erent mouse strains. Fig. S6 shows FACS analysis on CD4  +   T, 
          +   T, and c-kit  +   NBNT cells in mice treated with anti  –  IL-17RB mAb. 
Table S1 lists primers used for quantitative real-time PCR analysis. Online 
supplemental material is available at http://www.jem.org/cgi/content/
full/jem.20080698/DC1. 
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